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Abstract
Background: Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically important
viral diseases affecting swine industry worldwide. Despite routine farm vaccination, effective control strategies for
PRRS remained elusive which underscores the need for in-depth studies to gain insight into the host immune
response to vaccines. The current study aimed to investigate transcriptional responses to PRRS Virus (PRRSV) vaccine
in the peripheral blood mononuclear cells (PBMCs) within 3 days following vaccination in German Landrace pigs.
Results: Transcriptome profiling of PBMCs from PRRSV vaccinated and age-matched unvaccinated pigs at right
before (0 h), and at 6, 24 and 72 h after PRRSV vaccination was performed using the Affymetrix gene chip porcine
gene 1.0 st array. Comparison of PBMCs transcriptome profiles between vaccinated and unvaccinated pigs revealed
a distinct host innate immune transcriptional response to PRRSV vaccine. There was a significant temporal variation
in transcriptional responses of PRRSV vaccine in PBMCs accounting 542, 2,263 and 357 differentially expressed
genes (DEGs) at 6, 24 and 72 h post vaccination, respectively compared to the time point before vaccination
(controls). Gene ontology analysis revealed the involvement of these DEGs in various biological process including
innate immune response, signal transduction, positive regulation of MAP kinase activity, TRIF-dependent toll-like
receptor signaling pathway, T cell differentiation and apoptosis. Immune response specific pathways such as
cytokine-cytokine receptor interaction, chemokine signaling pathway, signal transduction, JAK-STAT pathway and
regulation, TRAF6 mediated induction of NF-kB and MAPK, the NLRP3 inflammasome, endocytosis and interferon
signaling were under regulation during the early stage of PRRSV vaccination. Network enrichment analysis revealed
APP, TRAF6, PIN1, FOS, CTNNB1, TNFAIP3, TIP1, CDKN1, SIRT1, ESR1 and HDAC5 as the highly interconnected hubs of
the functional network of PRRSV vaccine induced transcriptome changes in PBMCs.
Conclusions: This study showed that a massive gene expression change occurred in PBMCs following PRRSV
vaccination in German Landrace pigs. Within first 3 days of vaccine exposure, the highest transcript abundance was
observed at 24 h after vaccination compared to that of control. Results of this study suggest that APP, TRAF6, PIN1, FOS,
CDKN1A and TNFAIP3 could be considered as potential candidate genes for PRRSV vaccine responsiveness.
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Background
Porcine reproductive and respiratory syndrome (PRRS)
is an emerging viral infectious disease; clinically charac-
terized by reproductive failures in breeding sows and
respiratory disorders in growing pigs [1]. PRRS causes
huge economic loss, and is of major concern as animal
welfare issue in swine industry worldwide [2, 3]. The
disease is caused by an enveloped, positive-sense, single-
stranded RNA virus called porcine reproductive and
respiratory syndrome virus (PRRSV). The PRRSV, a mem-
ber of arterivirus group under the family arteriviridae, is
divided into two distinct genotypes namely European and
North American types [4]. The PRRSV genome is approxi-
mately 15 kb containing ten open reading frames (ORF)
encoded with seven structural and 14 nonstructural pro-
teins [5, 6]. The virulent PRRSV primarily infects pulmon-
ary alveolar macrophages, and destroy infected cells
through cytopathic replication. The host-virus interaction
results in a deficient host’s innate immune response indi-
cated by a poor induction of type I interferon (IFN α/β),
the potent antiviral immune responsive cytokines [7, 8].
Some of the non-structural proteins (Nsp1, Nsp2, Nsp11)
and a structural protein (N protein) of PRRSV are known
to be associated with IFN suppression in the infected cells
[4]. The RIG-I/MDA5 and JAK-STAT pathways are two
major signaling pathways for IFN production which
are found to be impaired by PRRSV during acute in-
fection [4]. Overall, the timing and the potency of the
host cellular and immunological events that occur fol-
lowing infection are likely potential determinants gov-
erning the pathogenesis [9].
Vaccination with modified live virus has been widely
practiced in the commercial swine herd as one of the
cost-effective control approaches for PRRS. The live
attenuated PRRSV vaccine provides sufficient protection
against homologous virus but limited protection against
reinfection of genetically variant strains [10]. Live viral
vaccines can efficiently trigger the activation of the host
immune system through evolutionarily conserved patho-
gen associated molecular patterns (PAMPs) allowing
their recognition by pattern recognition receptors (PPRs)
of immune cells [11]. Following administration, vaccine
antigen produces a ‘danger signals’ which activate the
monocytes and dendritic cells in such a way to secrete
proinflammatory cytokines and chemokines [12]. These
cytokines and chemokines lead the extravasation and
attraction of monocytes, granulocytes and natural killer
cells, and generate an inflammatory microenvironment,
in which monocytes differentiate into macrophages, and
immature dendritic cells become mature [13]. Through
changing the surface receptors, macrophages and
mature dendritic cells migrate towards the draining
lymph nodes and induce the activation of T and B
lymphocytes. T lymphocytes have two subsets namely
CD4+ and CD8+ T cell. The generation and mainten-
ance of both B cell and CD8+ T cell responses are
supported by growth factors and signals provided by
CD4+ T helper lymphocytes 1 and 2 (Th1 and Th2).
Th1 and Th2 are controlled by regulatory T cells
(Treg) involved in maintaining the immune tolerance [14].
The peripheral blood mononuclear cells (PBMCs) are the
population of immune cells which includes lymphocytes
(T cell, B cell and NK cells), monocytes and dendritic cells.
Altogether, they play a central role in immune system
against virus infection. Therefore, deciphering the PRRSV
vaccine induced global transcriptome changes in PBMCs
might lead to identify the molecules and signaling path-
ways associated with host immune responses.
The innate immune response against viruses like
PRRSV is critical as such virus is continuously changing
their antigenic epitopes [15]. Innate immune response is
the first line defense mechanism of host cells against for-
eign antigen which typically occurs within hours in a
non-specific manner and may persists for few days [15].
The innate immune system recruits effector cells upon
antigen exposure which secret cytokines, chemokines
and proteins and subsequently activate the adaptive im-
mune system [16]. By that means, the innate immune re-
sponse acts as precursor to initiate the adaptive
immunity against a specific pathogen [17]. Innate im-
mune traits have been considered as potential selection
goals for disease resistance in pig breeding as innate im-
munity is likely to provide a common protection mech-
anism against multiple pathogens [18]. Genome-wide
association study revealed a major quantitative trait
locus (QTL) on chromosome 4 (SSC4) associated with
host resistance to in-vivo PRRSV challenge [19]. The
association of this region on SSC4 with PRRS resistance
was further validated by the presence of single nucleo-
tide polymorphism (SNP) marker, WUR10000125
(WUR) in the same region [20, 21]. Candidate genes in
this locus on SSC4 include the interferon induced
guanylate-binding protein gene family which are func-
tionally linked to the innate immunity [22]. Therefore,
genes and molecular pathways associated with improved
innate immune response to PRRSV vaccine could
possibly be implemented in breeding program for PRRS
resistant pigs [18]. To this end, key molecules regulating
the transcriptional network of PRRSV vaccine induced
innate immune response in peripheral blood are highly
sought.
PBMCs are the primary immune cells in blood [23]
and have suitably been used for the evaluation of vaccine
induced global gene expression changes for several dis-
eases in human and non-human primates (reviewed by
[24]). The porcine PBMCs have also been used for
microarray analysis of immune response genes following
in-vitro lipopolysaccharide stimulation [25], in-vivo
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mycoplasma vaccination [26], and tetanus toxoid vaccin-
ation [27]. Transcriptional responses to natural as well
as experimental infection of PRRSV have been studied
through global gene expression profiling of pulmonary
alveolar macrophages in pig [28, 29]. However, little is
known about the global transcriptome alterations in per-
ipheral blood after PRRSV vaccination in pigs. Therefore,
the aim of this study was firstly to investigate the tran-
scriptional response to PRRSV vaccine in PBMCs of
vaccinated pigs compared to unvaccinated one. Secondly
to characterize the temporal patterns of global gene
expression changes in PBMCs over the first 3 days fol-
lowing PRRSV vaccination.
Methods
Study design and blood sampling
A total of 12 German Landrace female piglets were
housed in the pig research farm at Frankenforst, Univer-
sity of Bonn, Germany. Piglets were selected from two
sows farrowed at the same day; all piglets were clinically
healthy with no history of respiratory diseases and birth
defects. After weaning, experimental piglets were divided
into two groups: six in vaccinated and six in unvaccin-
ated group. The piglets of vaccinated group were vacci-
nated with a modified live PRRSV vaccine of European
strain (Porcilis® PRRS, MSD Animal Health, Germany)
with primary dose at day 28 and booster dose at day 56
of their age according to the routine farm vaccination
program. The unvaccinated group was maintained for
health control without vaccine treatment. About 8 mL
whole blood samples with 1.5 mL anticoagulant (0.5 M
EDTA) were collected at different ages and time points
before and after vaccination from pigs of both groups
(Additional file 1). The blood samples collected at day 7
of age from all piglets were used for screening the
PRRSV-specific maternally derived antibody response.
The blood samples collected at four time points (0 (be-
fore vaccination), 6, 24 and 72 h post vaccination (hpv))
following primary vaccination from both groups (except
0 h in unvaccinated group) were used for microarray
hybridization. Three individual biological replicates from
both groups were selected based on their RNA quality
for the microarray experiment. In addition, the blood
samples from all piglets collected just before, and two
weeks post primary vaccination as well as just before,
and 2 weeks post booster vaccination were used for
monitoring the vaccine induced antibody response by
ELISA (Additional file 1).
Isolation of PBMCs and plasma
PBMCs and plasma were separated from the whole
blood sample through density gradient centrifugation
(1500 rpm for 25 min) with Histopaque®-1077 (Sigma-
Aldrich, Munich, Germany) according to the protocol
described by Uddin et al. [30]. The PBMCs were washed
three times (pelleted at 1000 rpm for 5 min) using
phosphate-buffered saline with purity of 99 % deter-
mined by Wright-Giemsa staining.
Measurement of plasma antibody level
To monitor the PRRSV-specific antibody titre, the
plasma samples from all study animals collected at day
7, 28, 42, 56 and 70 of their age ((Additional file 1) were
screened by ELISA (PRRSV-AK screening, Synlab Vet
GmbH, Augsburg, Germany) according to manufac-
turer’s protocol. The optical density (OD) of each well
was measured at 650 nm using the Bio-Rad 680 micro-
plate reader. The presence or absence of PRRSV anti-
body was determined by calculating the sample to
positive (S/P) ratio. The S/P ratio was calculated accord-
ing to the following equation: S/P ratio (%) = 100 × [(OD
of test sample – Mean OD of negative controls)/(Mean
OD of positive controls – Mean OD of negative con-
trols)]. The samples were considered to be positive for
PRRSV antibody if the S/P ratio was more than 0.4 as
described by Kittawornrat et al. [31].
Isolation and quality control of total RNA
The total RNA was extracted from PBMCs using the
miRNeasy mini kit (P/N 217004, Qiagen, Hilden,
Germany) according to the manufacturer’s protocol
along with DNase treatment (P/N 79254, Qiagen,
Hilden, Germany). RNA concentration and purity were
measured by NanoDrop® spectrophotometry (ND-8000;
NanoDrop Technologies). RNA integrity was checked by
micro capillary electrophoresis on an Agilent 2100 Bioa-
nalyser with RNA 6000 Nanochip kit (Agilent Technolo-
gies, Waghäusel - Wiesental, Germany).
Microarray target preparation and hybridization
To prepare the target probes of 21 microarray, about
100 ng of total RNA samples from each of seven se-
lected time points were processed with the GeneChip®
WT PLUS Reagent kit (P/N 902281; Affymetrix Inc.,
Santa Clara, CA, USA) according to the manufacturer’s
protocol. In brief, the total RNA was subjected to
synthesize the first-strand cDNA containing a T7 pro-
moter sequence at the 5′ end followed by synthesis of
the second-strand cDNA by DNA polymerase in the
presence of RNase H. This double-strand cDNA was
subjected to in-vitro transcription with T7 RNA poly-
merase for synthesis of the antisense RNA (complemen-
tary RNA, cRNA). The cRNA preparation was then
purified using purification beads to improve its stability.
From 15 μg of purified cRNA, the sense-strand cDNA
(ss-cDNA) was synthesized by reverse transcription
using random primers. The ss-cDNA contained dUTP at
a fixed ratio relative to dTTP and the remaining cRNA
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was degraded by RNase H. After purification and quanti-
fication, 5.5 μg of ss-cDNA in a 31.2 μL volume was
fragmented by uracil-DNA glycosylase (UDG) and apyri-
midinic endonuclease 1 (APE 1) at the unnatural dUTP
residues and breaks the DNA strand. The fragmented
ss-cDNA was then labeled by terminal deoxynucleotidyl
transferase (TdT) using the Affymetrix proprietary label-
ing reagent that is covalently linked to biotin. The
hybridization of microarray probes followed by washing
and staining was performed with the GeneChip®
Hybridization, Wash and Stain kit (P/N 900720, Affyme-
trix Inc., Santa Clara, CA). For hybridization, about
130 μL hybridization cocktail containing about 3.5 μg of
biotinylated ss-cDNA probes was injected into the Gen-
eChip® Porcine Gene 1.0 ST array strip of 81/4 format
(P/N 901976, Affymetrix Inc., Santa Clara, CA, USA)
and incubated for 16 h in a hybridization oven (Gene-
Chip® Hybridization oven 640; Affymetrix Inc.) at 45 °C
with 60 rpm. The hybridized chips were stained and
washed in a fluid station (GeneChip® Fluidics Station
450; Affymetrix Inc.) and scanned by Affymetrix Gene-
Chip® scanner 3000 7G. The Affymetrix GeneChip®
Command Console™ (AGCC) software was used to
evaluate the array images and to export the reports of
spot intensity data in CEL file format.
Microarray data processing
Pre-processing, normalization and statistical analyses of
microarray dataset were performed using packages of
Bioconductor-platform implemented in R-project soft-
ware (v3.1.2) [32]. The ‘oligo’ package was implemented
for the RMA (Robust Multi-array Average) based quan-
tile normalization of microarray data at transcript level
[33]. For quality control, some diagnostic plots of the
raw intensity data were checked before and after the
normalization. After excluding two arrays at 72 h post
unvaccinated sample which did not pass the quality con-
trol, 19 arrays were used for further analysis. After
normalization, the main probes (19,218) of the array
were extracted. Then interquartile range (IQR) based
filtering (variance cutoff value 0.25) was applied which
further excluded about 4,978 low expressed probes.
Finally the expression dataset comprising 14,231 transcript
probes were subjected for downstream analysis. Probe to
gene transcript annotation was performed with recent
Affymetrix annotation file for assigned array [34]. Gene an-
notations were extended by their orthologous human gene
symbol as well as ensembl gene identifiers. Until otherwise
mentioned, downstream functional analyses of this dataset
were performed based on human genome database.
Characterization of phenotypic groups
To characterize the differences of transcriptional re-
sponses between pigs of vaccinated and unvaccinated
group, the annotated gene expression profiles of PBMCs
were subjected to an exploratory functional analysis
through gene set enrichment analysis (GSEA) algorithm
implemented in GSEA-P tool [35]. Two pairs of
vaccination-time point group (6 hp vaccinated vs. 6 hp
unvaccinated and 24 hp vaccinated vs. 24 hp unvaccin-
ated) were considered as input phenotype for this ana-
lysis. The normalized and filtered expression dataset of
12 arrays containing human orthologous symbols of
gene transcripts with their corresponding expression
values were uploaded into the GSEA-P to generate the
list of ranked order gene markers. The ‘immunologic sig-
nature’ catalog of gene set from Molecular Signatures
Database (C7: MSigDB v5.0, Broad Institute, Cambridge,
MA) was screened against the ranked gene list. The nor-
malized enrichment score (NES) of each gene set was
estimated by the number of over-representation of mem-
bers of gene set towards the top or bottom of the ranked
gene list through applying a weighted Kolmogrov-Smirnov
statistics [36]. Then the enrichment score p-values were
estimated using a phenotype based permutation test pro-
cedure. The statistical significance was defined by the cut-
off value of false discovery rate (FDR) <0.15 and the NES
p < 0.05.
Differential gene expression analysis
To explore the temporal variation of transcriptional re-
sponse to vaccination, differential gene expression
analysis was performed using the linear analysis of
microarray technique from the ‘limma’ package [37] with
empirical Bayes adjustment to the variance, followed by
Benjamini and Hochberg (BH) correction for multiple
testing [38]. To check whether there was temporal vari-
ation among the pigs of unvaccinated control group, two
contrast pairs (i.e. 0h_vac vs. 6h_unvac and 0h_vac vs.
24h_unvac) were tested. Then within the vaccinated
group, three pairwise comparisons (6 hpv vs. control; 24
hpv vs. control and 72 hpv vs. control) were taken in to
account for the differential expression analysis. Gene
transcripts were considered as differentially expressed
when passing the thresholds of false discovery rate
(FDR) of <0.01 and log2 fold-change either >1.5 or <
−1.5. The number of differentially expressed genes in
each contrast pair and their interaction were exported in
intersecting Venn diagram.
Gene ontology and pathway analysis
For biological interpretation of the transcriptome data-
set, the significantly over-represented gene ontology
terms and biological pathways were explored with the
InnateDB pathway analysis tool [39]. First, the identifiers
of DEGs from microarray data were converted to their
human ensembl orthologues using the BioDBnet tool
(http://biodbnet.abcc.ncifcrf.gov/). The list of ensembl
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gene identifiers was then uploaded in InnateDB web and
performed the over-representation analysis with imple-
mentation of the hypergeometric algorithm and the
Benjamini-Hochberg (BH) multiple test correction
method. The gene ontology (GO) and pathways were
considered significantly over-represented if they had a
FDR < 0.05.
Sub-network enrichment analysis
To visualize the PRRSV vaccine induced transcriptional
network as well as to identify the regulatory genes, the
sub-network analysis was performed using NetworkAn-
layst online tool [40]. This tool uses the InnateDB
(downloaded June 20, 2014) protein-protein interaction
(PPI) datasets comprised of 14,755 proteins and 145,955
experimentally validated interactions for human.
NetworkAnlayst implements the R package ‘igraph’ for
network analysis and ‘Gephi Toolkit’ for finalizing the
network layout. Human orthologous ensembl gene iden-
tifiers of the DEGs were uploaded into the NetworkAn-
layst to construct the interacting network. First, a
default network was assembled based on the Walktrap
algorithm taking only direct interaction of seed genes
(first-order interactors). The network size was then
adjusted for <500 seeds and 200 ~ 2000 nodes using the
‘reduce’ panel for high-performance visualization. Two
topological measures such as degree (number of connec-
tions to other nodes) and betweenness centrality (num-
ber of shortest paths going through the node) were
taken in to account for detecting highly interconnected
hubs of the network. Centrality measures of hub nodes
were evaluated serially with degree followed by between-
ness. Nodes having higher degree and betweenness
values were considered as potentially important network
hubs in cellular signal trafficking. Finally, weighted net-
work based module detection was perform to cluster the
genes of similar biological functions. The p value of a
given network module was calculated using a Wilcoxon
rank-sum test of the “internal” (edges within in a mod-
ule) and “external” (edges connecting the nodes of other
modules) degrees. The p values were calculated based
on their connectivity assuming null hypothesis that there
is no difference between the number of “internal” and
“external” connections to a particular node in the mod-
ule. Module having more internal than external edges
was like to be significant. The functional enrichment of
modules was performed with REACTOME.db pathway
database incorporated in this tool for comprehensive
biological illustration of the network.
Quantitative real-time PCR (qRT-PCR)
For technical validation of microarray results, five se-
lected DEGs (Table 1) known to be involved in immune
response function were quantified by qRT-PCR in the
same RNA samples as used for microarray expression.
Primers were designed based on an open source primer
designing software Primer3 [41]. First Strand cDNA Syn-
thesis Kit (P/N K1612, Thermo Scientific, Co.) was used
for reverse transcription with oligo (dT) primer. The
qRT-PCR reaction was set up taking 1.0 μl of cDNA
template, 8.0 μl of deionized RNase free water, 0.5 μM of
upstream and downstream primers, and 10 μl iTaq™ Uni-
versal SYBR® Green Supermix (Bio-Rad laboratories
GmbH, Germany) in a total reaction volume of 20 μl
and were amplified by the StepOnePlus™ Real-Time
PCR System (Applied Biosystems®, Darmstadt,
Germany). The thermal cycling conditions were 95 °C
for 3 min, 95 °C for 15 s, 6 °C for 45 s (40 cycles);
95 °C for 15 s, 62 °C for 1 min, 95 °C for 15 s. All
reactions were run in duplicate and the average value
was used for calculating the expression value. Gene-
specific expression was measured as relative to the
geometric mean of the expression of two
Table 1 Primer sequences for used qRT-PCR validation. List of
primers and their sequences of selected candidate genes used
for qRT-PCR validation of microarray data
GenBank Gene name Primer sequence (5′-3′)
Accession
number






NM_001044580 STAT3 : Signal transducer




































a are the house keeping genes used for normalization
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housekeeping genes (GAPDH and ACTB) (Table 1).
The delta delta Ct (ΔΔCt) method was used for cal-
culating the difference between target gene and refer-
ence genes [42]. The correlation between microarray
and qRT-PCR results was analyzed by Spearman’s
Rho test. The significance level was set as p < 0.01.
Results
PRRSV-specific antibody responses
In order to exclude the maternally derived antibody
(MDA) response of PRRSV as well as to evaluate the
vaccine induced antibody response, plasma samples from
all pigs at day 7, 28, 42, 56 and 70 of age were screened
by ELISA. The plasma antibody level confirmed that ex-
perimental pigs were negative for MDA of PRRSV con-
sidering the sample to positive (s/p) ratio of 0.4 (40 %)
as threshold (Fig. 1). The optical density (OD) values in-
dicated a relatively higher MDA titre in suckling piglets
which felt down and remained stable towards the base
line along with increased age of unvaccinated pigs. On
the other hand, there was an increasing trend of plasma
antibody titre in pigs following vaccination. The anti-
body titre got above the threshold after 2 weeks, and
subsequently reached a plateau after 4 weeks of the pri-
mary vaccination (Fig. 1).
Transcriptome profiles of PBMCs following PRRSV
vaccination
To uncover the transcriptional modification underlying
the innate immune response to a live attenuated PRRSV
vaccine, we performed the global transcriptome profiling
of PBMCs from pigs of vaccinated group at before (con-
trol) and 6, 24 and 72 h after vaccination; and from
unvaccinated group at 6, 24 and 72 h post vaccination
time points using the Affymetrix GeneChip Porcine
Gene 1.0 ST Array. This array was encoded with 394,580
probe (20–22 probes per gene) representing a total of
19,212 known genes. After normalization the current
study identified a total of 27,558 probes having higher
signal intensity than the background. After filtering,
14,231 transcripts were found to be expressed in
PBMCs, 10,217 of which could be annotated and were
implemented in the downstream analyses.
Variation of PBMCs transcriptome profiles between
vaccinated and unvaccinated pigs
The gene set enrichment analysis (GSEA)-based com-
parison of genome-wide expression profiles has distin-
guished the vaccine induced transcriptome changes
between the vaccinated pigs and the age-matched un-
vaccinated control pigs. The GSEA algorithm revealed
that a total of 42 and 36 gene sets (pathways) were
significantly upregulated at 6 and 24 hpv in vacci-
nated group, respectively, compared to their unvaccin-
ated counterparts. Of these, the chemokine signaling,
JAK-STAT signaling and cytoskeleton activation are
the most significantly enriched gene sets which indi-
cated the potential of vaccine to switch on the tran-
scriptional machinery in PBMCs (Additional file 2).
The enrichment score of most of the up regulated
gene sets in the vaccinated group was increased at 24
hpv from that of 6 hpv indicating the number of core
genes of particular gene set increased over the time of
immunization (Table 2).
Differential gene expression in PBMCs after PRRSV
vaccination
To get a comprehensive overview of transcriptional
modifications associated with innate immune re-
sponse, we performed the differential gene expression
analysis over three time points (6, 24 and 72 hpv)
after vaccination compared to the control (before vac-
cination). The normalized expression values for only
main probes of the chip were included for differential
expression analysis and filtered by the thresholds of
FDR <0.01 and log2 fold-change >1.5 or < −1.5. Using
this criterion, 2,453 transcripts were found to be dif-
ferentially expressed in PBMCs after PRRSV vaccin-
ation. Among them, 1087 (44.31 %) gene transcripts
could be annotated. A complete list of the differentially
Fig. 1 PRRSV-specific antibody responses. The figure depicts the
reactivity of maternally derived antibody and vaccine derived
antibody to PRRSV in plasma detected by PRRSV-AK Enzyme
Immunoassay. Values in the Y-axis represent the sample to positive
(s/p) ratio, and the s/p values of 0.4 was considered as threshold to
classify the individuals either positive or negative. Values in X-axis
represents the piglet ages at which blood samples were evaluated.
Primary and booster vaccination were performed at day 28 and 56 of
age, respectively in pigs of vaccinated group. In vaccinated group, the
optical density (OD) values of samples at day 7 and 28 of age represent
for maternally derived antibody (MDA), and samples at day 42, 56 and
70 for vaccine induced antibody response. While samples from the
control group were used for only monitoring the way of declining the
MDA over the age of animals in absence of further PRRSV exposure
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expressed genes (DEGs) in PBMCs at three time points
following PRRSV vaccination is provided in Additional
files 3, 4 and 5.
The number DEGs and their direction of expression in
three pairwise comparisons are plotted in Fig. 2. A total
of 542 DEGs including 423 up regulated and 119 down
regulated genes were detected at 6 hpv. The highest
number (2, 263) of DEGs was identified at 24 h post vac-
cination. The number of upregulated genes (2,060) was
also much higher than the down regulated ones (203) at
24 hpv. A total of 357 genes showed differential
expression at 72 hpv in which 188 and 169 were up
and down regulated, respectively. The fold change
(FC) of differential expression ranged from −3.76 to
3.94; from −3.7 to 4.45 and from −4.15 to 3.11 at 6
hpv, 24 hpv and 72 hpv, respectively. A higher pro-
portion of up regulated genes at each comparison in-
dicated that vaccination induces active gene
expression processes which may be associated with
development of innate immune response.
The intersecting Venn diagram (Fig. 3) revealed that
44, 1,733 and 128 genes showing differential expres-
sion exclusively at 6, 24 and 72 hpv, respectively.
Among the time point specific DEGs, 32, 1, 404 and
88 were up regulated and 12, 329 and 30 were down
regulated at 6, 24 and 72 hpv, respectively. On the
other hand, 161 genes showed differential expression
constantly over the 3 days of post vaccination.
Differential expression of 480 genes shared between
the time points of 6 hpv and 24 hpv; 211 genes be-
tween 24 hpv and 72 hpv, and 179 genes shared be-
tween 6 hpv and 72 hpv time points.
Hierarchical clustering of DEGs in PBMCs following
vaccination has also provided a clear image of genes that
Table 2 Significantly enriched gene sets (pathway) obtained from gene set enrichment analysis. Top most gene sets enriched in
PBMCs of PRRSV vaccinated pigs compared to unvaccinated control pigs exported from GSEA desktop application
Gene sets 6hpv_vacc vs. 6hpv_unvacc 24hpv_vacc vs. 24hpv_unvacc
NES FDR NES FDR
Regulation of actin cytoskeleton 2.51 0.001 2.75 0.001
Chemokine signaling pathway 2.48 0.001 2.56 0.001
JAK-STAT signaling pathway 2.39 0.001 2.55 0.001
Integrin cell surface interactions 2.46 0.001 2.5 0.001
Cell adhesion molecules 2.31 0.001 2.38 0.001
Integrin signaling pathway 2.28 0.001 2.37 0.001
Cell surface interactions at the vascular wall 2.27 0.001 2.33 0.001
Signal transduction by L1 2.24 0.007 2.27 0.007
Cytokine cytokine receptor interaction 2.20 0.008 2.25 0.007
Apoptosis by serum deprivation up 2.17 0.008 2.23 0.007
Immortalized by HPV31 DN 2.16 0.008 2.23 0.008
Signaling by FGFR1 mutants 2.14 0.011 2.21 0.010
TNF signaling up 2.12 0.014 2.19 0.013
ECM receptor interaction 2.10 0.025 2.13 0.021
TRAF trafficking pathway 2.08 0.013 2.12 0.011
Leukocyte transendothelial migration 2.04 0.008 2.14 0.007
NES normalized enrichment score, FDR false discovery rate
Fig. 2 Number of differentially expressed genes after PRRSV
vaccination. The figure depicts the number and direction of
DEGs identified at three time points (6, 24 and 72 hpv) of PRRSV
vaccination compared to the control (before vaccination)
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were regulated in the same or opposite direction in
response to vaccination (Fig. 4). There was distinction
among time points of vaccine exposure in terms of up
or down regulation of DEGs as well. A quite remarkable
difference was observed at 24 h post vaccination com-
pared to that of control. The hierarchical cluster analysis
(HCA) indicates a good cluster of replicate piglets within
the group which is suggestive for the homogeneity of the
experimental blocks.
GO and pathways enriched by PRRSV vaccine induced
DEGs
A GO classification of biological processes involved with
all differentially expressed genes in PBMCs after PRRSV
vaccination is provided in Table 3. The GO categories
with a direct relation to immune response function
includes innate immune response, signal transduction,
viral process, T cell differentiation, chemotaxis, re-
sponse to light stimulus, cytokine-mediated signaling
pathway, complement activation, cell death, cell pro-
liferation and immune system process. Highest repre-
sentation of genes involved with particular GO terms
was observed at 24 hpv compared to 6 hpv and 72
hpv. The pathway analysis paints a similar picture to
the GO terms. The statistically significant biological
pathways involved with PRRSV induced DEGs are
presented in Fig. 5. Among the top pathways, cyto-
kine-cytokine receptor interaction, chemokine signaling
pathway, signal transduction, JAK-STAT pathway and
regulation, TRAF6 mediated induction of NF-kB and
MAPK, the NLRP3 inflammasome, endocytosis and
interferon signaling were activated. The majority of
genes involved in corresponding pathways were up
regulated after vaccination.
Transcriptional network of PRRSV vaccine induced innate
immune responses in PBMCs
The network analysis retrieved one giant subnetwork
herein called the global network and 12 other smaller
networks. The global network was comprised of 432
seed genes or nodes and 850 edges or connections. The
diameter of each node corresponds to the values of two
centrality measures (degree and betweenness) and
thereby a larger diameter indicates higher potential of
particular node to be a hub of the network (Fig. 6). The
values of degree and betweenness centrality of all seed
genes are presented in Additional file 6. Based on these
two centrality measures, APP (Amyloid beta (A4) pre-
cursor protein) was determined to be the top most po-
tential hub gene of the global network having highest
values of degree (118) and betweenness centrality (6468).
Other potential hubs includes TRAF6 (TNF receptor-
associated factor 6), PIN1 (Peptidyl-prolyl cis-trans
isomerase NIMA-interacting 1), FOS (FBJ murine osteo-
sarcoma viral oncogene homolog), CTNNB1 (Catenin
(cadherin-associated protein) beta 1), CDKN1A (Cyclin-
dependent kinase inhibitor 1A (P21, Cip1)-A), TNFAIP3
(Tumor necrosis factor, alpha-induced protein 3), SIRT1
(Sirtuin 1), ESR1 (Estrogen receptor 1) and HDAC5
(Histone deacetylase 5).
The NetworkAnalyst tool has detected five signifi-
cant (p <0.01) network modules within the global net-
work which are indicated by different colors (Fig. 6).
Each module was led by one or more of the above
mentioned hubs connected too many other genes of
similar biological function. Functional enrichment of
the modules revealed that PRRSV vaccine induced
transcriptional modification involves five major groups
of biological functions such as innate immune re-
sponse; development and differentiation of blood cell;
cell death, cell cycle and survival; ubiquitination and
glycosylation; and protein metabolism and regulation
of gene expression. In particular, the functional
involvement of the APP led network module (red
module) includes membrane trafficking (RAB5C,
ARRB1, SEC24C, TBC1D1), chemokine receptor binding
(CXCR2, CXCL16), interferon signaling (IFNA8, IFNW1),
post-translational protein modification (PIGO, GALNT12,
MPI, SEC24C) and asparagine N-linkage glycosylation
(MPI, SEC24C).
To test whether these hub genes can coordinate the
global transcriptional network, we constructed the
second network (herein called the core network) tak-
ing the top thirteen hubs of global network as seed
genes. The higher-order interactions of the core net-
work assembled about 3,764 nodes and 5, 145
Fig. 3 Intersecting Venn diagram showing the abundance of DEGs.
The number of genes differentially expressed at three different time
points (6, 24 and 72 hpv) of PRRSV vaccination compared to the
control (before vaccination). The numbers in overlapping area(s)
represent the differential expression of genes shared among the
time points
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connections which reflected the global network. The
simplified interconnection among the hub genes is
presented in the core network (Fig. 7). Among the
hub nodes, six (APP, TRAF6, PIN1, FOS, CDKN1A
and TNFAIP3) were found to be directly involved
with innate immune system and were upregulated in
immunized PBMCs. APP, TRAF6, PIN1, FOS and
TNFAIP3 have direct connection with six, five, five,
four and three other hubs, respectively. TRAF, APP,
CTNNB1, ESR1 and HDAC5 together are responsible
signal transduction process. TRAF6 along with FOS
participate in toll-like receptor cascades, MAPK sig-
naling, MyD88 dependent & independent cascades
and proinflammatory response. TRAF6 and PIN are
involved in RIG-1/MDA5 mediated induction of
alpha-beta interferon.
Validation of microarray data
Microarray data was validated through measuring the
relative expression level of five differentially expressed
genes (STAT3, IRF3, CD80, CCL4 and TRAF6) in
PBMCs using qRT-PCR. The expression data (Additional
file 7) obtained from microarray and qRT-PCR for the
selected genes are plotted in Fig. 8. The qRT-PCR ex-
pression values of all five genes confirmed statistically
significant (p < 0.01) differential expression in the same
Fig. 4 Hierarchical heat map showing differential gene expression over time. Normalized log2 transformed values as determined by Affymetrix
GeneChip® porcine gene 1.0 ST array in PBMCs of German Landrace pigs at 6, 24 and 72 h post PRRSV vaccination. The cutoff value of log2 fold
change as either ˃1.5 or ˂ −1.5 and FDR <0.05 was considered for statistical significance. Each column represents one array from each of
replicate piglets
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direction as the microarray data with a correlation (cor-
relation coefficient, r = 0.949).
Discussion
Protective immunity to PRRS virus is a complex and un-
resolved issue. To date, the live attenuated virus vaccine
has been considered to be the most economic method to
achieve immunity and protecting herds from losses asso-
ciated with infections by highly virulent strains of
PRRSV [43]. In the current study, the antibody response
appeared to start at 2 weeks of primary vaccination and
reached a steady state at 4 weeks after primary vaccin-
ation in pigs (Fig. 1). This reflects the previous reports
stating that PRRSV specific antibodies begin to appear in
the infected pigs as early as 7 –10 days post infection
with a low titre [44] followed by delayed production of
neutralizing antibody (NAb) between 2 and 4 weeks post
infection [44]. Besides neutralizing antibody, compo-
nents of innate and cell mediated immune responses
have major contribution to the viral clearance in immu-
nized animals. Moreover, the character of the innate im-
mune response to virus is thought to dictate the quality
of subsequent adaptive immune response [45]. There-
fore, we focused our transcriptome analyses on the in-
nate immune response to vaccination.
To investigate the host-vaccine interaction, we gener-
ated the whole transcriptome profiles of PBMCs following
in-vivo PRRSV (EU strain) vaccination in German Land-
race pigs so far for the first time. Although some authors
conducted gene expression studies on porcine PBMCs to
evaluate the immune response to PRRSV [46, 47], but
these were focused to in-vitro model with expression
profiling of selected candidate genes. PBMCs are het-
erogeneous population of immune cells including
monocytes, lymphocytes (T Cells, B cells, and NK
cells) and dendritic cells. The frequency of proportion
of PBMC-subpopulation may vary across individuals
[48]. The vaccine induced cellular activation and dif-
ferentiation may changes the proportion of sub-types
of PBMCs, which are likely contribute to gene expression
changes [49]. Thus, the current analyses have limitation in
evaluating the cell type specific contribution on vaccine
responses. In fact, the reports on, and option for, specific
cell subset are limited in swine and mostly due to the rela-
tive lack of immune-tagged reagents critical for such detail
phenotyping (reviwed by Schroyen and Tuggle [50]).
However, specific cell type contribution could be partially
addressed by bioinformatics approach of gene expression
deconvolution. Indeed, the unfractionated PBMCs sam-
ples were analyzed in this study as a rapid and convenient
model for monitoring the host transcriptional response to
PRRSV vaccination.
With the global PBMCs transcriptome profiles, we
first performed an exploratory functional analysis to
Table 3 Gene ontology terms enriched by the DEGs. Top 30
GO terms of biological process involved with the vaccine
induced DEGs retrieved from InnateDB pathway analysis tool.
The significance of over-representation was defined by multiple
test corrected p-value of <0.05
Time
points





6 hpv GO:0045087 Innate immune response 18 0.01
GO:0042493 Response to drug 9 0.05
GO:0034097 Response to cytokine 5 0.02




GO:0044281 Small molecules metabolic
process
30 0.01
GO:0015031 Protein transport 10 0.03
GO:0006355 Regulation of transcription,
DNA-template
28 0.03
GO:0007186 G-protein coupled receptor
signaling pathway
15 0.03
GO:0044267 Cellular protein metabolic
process
14 0.03
24 hpv GO:0045087 Innate immune response 90 0.01
GO:0007165 Signal transduction 82 0.01
GO:0008284 Positive regulation of cell
proliferation
45 0.02
GO:0016032 Viral process 37 0.01
GO:0051607 Defense response to virus 14 0.02
GO:0043406 Positive regulation of
MAPK kinase activity
9 0.05
GO:0006874 Cellular calcium ion
homeostasis
11 0.08
GO:0007265 Ras protein signal
transduction
8 0.02




72 hpv GO:0043408 Regulation of MAPK cascade 7 0.04




GO:0006935 Chemotaxis 4 0.04
GO:0007155 Cell adhesion 7 0.05
GO:0051726 Regulation of cell cycle 9 0.05
GO:0055085 Transmembrane transport 14 0.03
GO:0010467 Gene expression 6 0.05
GO:0006915 Apoptotic process 8 0.04
GO:0009615 Response to virus 5 0.14
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Fig. 5 Biological pathways involved with the DEGs following PRRSV vaccination. The figure depicts the top ten biological pathways regulated by
the DEGs in each of three pairwise comparisons. Values in X-axis represents the number of over-expressed genes (red portion of bar) and under-
expressed genes (green portion of bar) involved in corresponding pathways. Pathways included here only having the over-representation p < 0.05
obtained from InnateDB. The upper part of graph (6 hpv) represents the top ten pathways regulated by DEGs found at 6 h, the middle (24 hpv)
for that of 24 h and the bottom one (72 hpv) for that of 72 h of post vaccination time points compared to the control (before vaccination)
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characterize the phenotypic groups using GSEA algo-
rithm. The GSEA first ranks all genes expressed based
on the correlation (positive or negative) of their expres-
sion values with one of two phenotypes tested, then
seeks the significance of over-representation of pre-
defined gene sets (pathways) with the ranked gene list
[36]. By this way, GSEA focused on identifying the path-
ways, not the individual genes differentially expressed
between two contrast phenotypic groups. The GSEA-
based analysis revealed significant enrichment of im-
munity related gene sets including chemokine signaling,
JAK-STAT signaling and cytoskeleton activation
Fig. 6 Global transcriptional network of PRRSV vaccine response in PBMCs. The picture depicts the interconnected network of PRRSV vaccine
induced differentially expressed genes in PBMCs at 24 hpv. Each circle indicates the node or member genes of the network. The diameter of the
circle corresponds to the values of two centrality measures that is degree and betweenness of particular gene. The larger diameter indicates the
higher potential of the nodes to be the hub genes of the network. The network modules with corresponding genes are indicated by different colors
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(Additional file 2) in vaccinated PBMCs compared to
that of unvaccinated one, which indicated the PRRSV
vaccine potential to enhance the host’s innate immunity.
This was consistence with the findings of a meta-
analysis done by Badaoui et al. [51] who reported that
the host-specific response to PRRSV challenge would
be associated with the activation of canonical path-
ways like TREM1, toll-like receptor and hyper-
cytokinemia/hyper-chemokinemia signaling. In addition,
the hybridization values of selected cell surface marker
genes including CD4, CD14, CD19, CD33 and CD86
(Additional file 8) indicated the changes of the propor-
tion of PBMC-subpopulation following vaccination.
This difference also justified the application of GSEA to
distinguish the transcriptional responses between
vaccinated and unvaccinated pigs through highlighting
only those pathways important in the mechanism of in-
nate immunity.
Followed by the gene set enrichment analysis, we
performed the differential gene expression analyses in
a time-series contrast which revealed that transcrip-
tome alteration started at 6 hpv and peaked at 24 hpv
followed by a decreased abundance at 72 hpv (Fig. 3).
The differential expressions of five selective genes
were confirmed by qRT-PCR (Fig. 8). It is noteworthy
that the comparison between 6 and 24 h time points
in unvaccinated group with that of 0 h in vaccinated
group yielded about ~20 differentially expressed genes
(data not shown) which were almost identical in both
contrast pairs and did not lead to enrichment of any
known immune response pathways. That indicated
there was no significant variation among pigs having
no vaccine exposures. Therefore, before vaccination
(0 h) time point were used as control to compare
with post vaccination time points. This was also sup-
ported by a similar study [27] where the pre vaccin-
ation samples have been used as control to investigate
the temporal pattern of transcriptomic response in
porcine PBMCs to Tetanus toxoid vaccine. The pro-
portion of up regulated genes was much higher than
the down regulated genes at all three time points in-
dicated the potential of PRRSV vaccine to induce gene
expression in PBMCs. The differential gene expression
analysis of the present study showed massive changes
in the transcript abundance of known immune re-
sponse genes and of genes that have been implicated
in PRRSV infection by several authors [3, 52, 53].
Xiao et al. [3] reported that 4,520 genes were differen-
tially expressed in porcine lungs at 96 and 168 h after
in-vivo infection with highly pathogenic PRRSV strain,
and those altered genes were functionally linked to
host innate immune responses.
The InnateDB pathway analyses of DEGs revealed that
transcriptome modification caused by vaccination are
involved with activation of pathway such as toll like
receptor 7/8 cascade, endocytosis, cytokine signaling,
chemokine signaling, signal transduction, MAPK activa-
tion in TLR cascade and JAK/STAT signaling pathway.
These pathways are known to be involved in the process
of host cell sensing of the viral antigen and subsequent
induction of innate immune response. Innate immunity
against viral antigen is initiated once after sensing of
viral pathogen-associated molecular patterns (PAMPs)
by the specific host cell pattern recognition receptors
(PRRs) such as toll-like receptors 3, 7 and 8 (TLR3,
TLR7 and TLR8) [54]. We observed the up regulation of
TLR3 and TLR7 in PBMCs after vaccination and genes
of signal transducers and activators of transcription
(STAT) family. The recognition of viral PAMPs (ss RNA
Fig. 7 Core transcriptional network of PRRSV vaccine response in
PBMCs. The picture depicts the connection among the regulatory
genes of the global transcriptional network of PRRSV vaccine
response in PBMCs. Only the direct connections among seed genes
are presented. The diameter of the circle corresponds to the values
of two centrality measures that is degree and betweenness of
particular gene. Among the hubs, nodes of blue colors were known
to be strongly involved in innate immune response function
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for PRRSV) by the host cell TLR results in a cascade of
intracellular signaling through various adapter molecules
(e.g. MyD88, MDA5, TRAF6) followed by activation of
the MAP kinase family, which in turn switch on tran-
scription factors such as interferon regulatory factors
(IRFs) and NF-kB [54]. Among the IRF family members,
IRF2, IRF2BPL, IRF5 and IRF7 were up regulated but
IRF3 was down regulated in PBMCs after vaccination. It
has been reported that the members of IRF family such
as IRF3, ISGF3, ISG15, IKKα, STAT1/STAT2 are involved
in immunosuppressive effects of PRRSV infected cells
[55, 56]. The NF-kB induces several downstream signal-
ing leading to the up regulation of proinflammatory
cytokines, chemokines and type-I interferon which in
turn facilitate the inflammatory process, apoptosis and
phagocytosis [57], which are key cellular process of
innate immunity.
Finally we performed the network analysis to extract
the regulatory molecules for vaccine responses. The net-
work analysis revealed that genes including APP, TRAF6,
PIN1, FOS, CDKN1A, CTNNB1, TNFAIP3 SIRT1, ESR1
and HDAC5 are the most highly interconnected hubs of
vaccine induced transcriptional network in PBMCs
(Fig. 6). The common feature of these master switch
genes is that they regulate the induction of several path-
ways of the innate immune responses including TLR
signaling, MAPK kinase cascades, interferon signaling
and advanced glycosylation endpoint receptor signaling.
This is in line with the recent report on detection of
network module containing numerous immune response
genes through weighted gene co-expression network
analysis of whole blood transcriptome profiles of PRRSV
infected pigs [58]. Amyloid beta (A4) precursor protein
(APP), the top hub gene, is a protein coding gene which
induces the secretion of a number of peptides; two of
the peptides were shown to have antibacterial and anti-
fungal activities [59]. The APP has been reported to be
over expressed in porcine alveolar macrophages 24 h
after in-vitro stimulation with PRRSV [60]. The network
module led by APP has functional involvement with
asparagine N-linked glycosylation of surface glycoprotein
3 (GP3) of PRRSV which regulates the neutralizing anti-
body response [61]. Therefore, the APP led gene net-
work module might contribute to PRRSV vaccine
induced transcriptional responses in PBMCs.
TNF receptor-associated factor 6 (TRAF6) was found to
be another prominent hub gene for transcriptional net-
work induced by PRRSV vaccination in PBMCs. The
TRAF6 is an adapter molecules required for TLR (TLR7/
8) induced signal transduction leading to expression of
IFNs [62]. The peptidyl-prolyl cis-trans isomerase-1
(PIN1) is a nucleus protein which has an essential role in
toll-like receptor signaling and type-1 interferon mediated
innate immunity. TLR7 and TLR9 activate the isomerase
PIN1 which subsequently activates the IRAK1, IRAK2 and
IRF7 and induces type I interferons [63]. It appeared that
among the top network hubs, APP, TRAF6 and PIN1 are
known to be involved in the interferon response, the most
potential antiviral innate immunity. Both TRAF6 and
PIN1 are located in Sus scrofa chromosome 2 (SCC2),
where the QTL for interferon-gamma level has already
been identified [64]. However, no QTL for immune re-
sponse capacity have been reported yet on the SSC13
where APP is located. Another hub gene, FOS, is a nuclear
phosphoprotein involved in signal transduction, cell pro-
liferation and differentiation, has been reported to regulate
Fig. 8 The qRT-PCR validation of the microarray data. The picture depicts the correlation between microarray (X-axis) and qRT-PCR (Y-axis)
expression data (Log2 fold-change) for five selected genes at three different time points (6, 24, 24 hpv) both in vaccinated and unvaccinated pigs.
Correlation between microarray and qRT-PCR data was analyzed by Spearman’s Rho test. The correlation coefficient was = 0.949, with a statistical
significance of p < 0.01
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the replication of hepatitis-c virus [65]. The cyclin-
dependent kinase inhibitor 1A (CDKN1A) is a protein
coding gene known to be involved in antiviral immune re-
sponse in human [66]. Both FOS and CDKN1A are
located on chromosome 7 (SSC7) where at least two
QTLs for PRRS resistance as well as QTL for other innate
immune response trait have been reported [67]. Tumor
necrosis factor alpha-induced protein 3 (TNFAIP3) is also
found as hub of the transcriptional network of PRRSV
vaccine response in PBMCs. The TNFAIP3 is a ubiquitin
editing enzyme, known to be involved in inflammatory re-
sponses signaled by cytokines, such as TNF-alpha and IL-1
beta, or pathogen sensing via toll-like receptors (TLRs)
through terminating NF-kappa-B activity [47]. TNFAIP3 is
located on chromosome1 (SSC1) where at least three
QTLs for PRRS susceptibility has been reported [19, 21,
67]. There were two close enzymatic products SIR1 and
HDAC5 also found as hubs of the transcriptional network.
SIRT1 deacetylates a wide range of substrates, including
p53, NF-kB, FOXO transcription factors, and PGC-1α,
with roles in cellular processes ranging from energy me-
tabolism to cell survival [68]. However, HDAC5 had
strong connection only with ESR1 in the core network.
The ESR1 was also found to be in the list of top ten hub
genes of the network which was over expressed in vacci-
nated PBMCs. ESR1 along with PRLR, FSHB, EPOR and
RBP4 were reported to have significant association with
swine reproductive traits [69]. Though reproductive fail-
ure is one of the major clinical outcomes of PRRSV
infection in breeding sows, ESR1 does not currently have
known roles in innate immunity to PRRSV and warrants
further investigation. On the whole, the hub genes includ-
ing APP, TRAF6, PIN1, FOS, CDKN1A and TNFAIP3
(Fig. 7), among others, were found to be highly intercon-
nected to maintain the innate immune response function.
Therefore, these six hub genes would coordinately be able
to control the transcriptional network of PRRSV vaccine
induced innate immune responses in PBMCs.
Conclusions
Herein, we performed microarray-based transcriptome
profiling to investigate genes, pathways and networks that
may be involved in innate immune response of PBMCs to
PRRSV vaccination in German Landrace pigs. This study
identified APP, TRAF6, PIN1, FOS, CDKN1A and TNFAIP3
as potential hub genes which could contribute to the func-
tional network of PRRSV vaccine induced transcriptome
alteration in PBMCs. Improvement of host genetic resist-
ance has recently been considered as a prospective way for
sustainable PRRS control. As direct measurement of dis-
ease resistance is very difficult, an indirect approach
through identification of genomic marker associated with
innate immune response to PRRSV vaccine is recommend-
able. Therefore, it would imply that hub genes of the
functional network identified in this transcriptome analysis
might be considered for future research to investigate their
potential role in PRRS resistance in pigs. However, the gen-
etic diversity among the pig breeds might contribute to the
variation of PRRSV vaccine responsiveness. The correlation
between early stage gene expression pattern and the anti-
body response of PRRSV vaccination could also be tested
in larger pig population.
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